Ahmed Bennis: Understanding Anticoagulant Related Kidney Injury
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X about a recent article by Yiwen Chen et. al, published in Clinical Kidney Journal, adding:
“Recent advances in anticoagulant-related nephropathy: risk factors, peribiopsy and therapeutic anticoagulation.
Definition: AKI or worsening of CKD caused by anticoagulant use. First proposed in 2009, with more than 140 cases reported by 2025.
Risk factors: CKD, IgA nephropathy, advanced age, comorbidities.
Diagnosis: Needs renal biopsy to exclude other causes. Hallmarks are extensive intratubular RBCs and/or RBC casts and ATN, without active glomerulonephritis.
Treatment: Supportive, with restoration of target anticoagulation.
Peribiopsy anticoagulation depends on the thrombotic risk of the primary disease and the characteristics of the anticoagulant.
ARN is linked to poor survival and kidney outcomes.
Evidence is case-level, so individualize care.”
Title: Recent advances in anticoagulant-related nephropathy: risk factors, peribiopsy and therapeutic anticoagulation
Authors: Yiwen Chen, Hao Yan, JingJing Wu, Huixia Liu, Yujuan Li, Ye Yao, Chun Zhang, Jing Xiong

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 3, 2026, 16:18Mira Kassouf: Reactivating An Embryonic Gene To Treat α-Thalassemia
-
Oct 3, 2026, 15:49Behnood Bikdeli: COATED_AIR Trial Design Published as Enrollment Reaches 3,000 Patients
-
Oct 3, 2026, 15:25Vanrose Panashe Nyamangodo: A Multi-Task Deep Learning Model For Malaria And Anemia
-
Oct 3, 2026, 14:52Benny Sorensen: Glanzmann’s Thrombasthenia Finally Assigned Dedicated ICD-10 Code
-
Oct 3, 2026, 14:52The Real-World Burden Of DVT In Traumatic Fractures – ISTH
-
Oct 3, 2026, 14:41How Much Do We Really Know About The Global Burden Of Venous Thromboembolism? – World Thrombosis Day
-
Oct 3, 2026, 14:35Nnadozie Gabriel C.: Understanding Hemophilia – Modern Breakthroughs and the Gap in Global Access
-
Oct 3, 2026, 14:26Björn Mulder: Differentiating PRP Formulations and Cell Counts in Knee and Ankle OA
-
Oct 3, 2026, 14:25Jorge Enrique: Personalised Strategies for Thrombosis Management in Cancer-Associated Cases